Výsledky vyhledávání - "Hervé Salomon"

Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients

Autor: Jean-Pierre Després, Hervé Salomon, Isabelle Lemieux

Publikováno v: Annals of Medicine. 35:442-448

Apolipoprotein (apo) CIII plays an important role in the catabolism of triglyceride-rich lipoproteins as it is a potent inhibitor of lipoprotein lipase (LPL). A low LPL activity has been simultaneously associated with hypertriglyceridemia, low HDL ch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b453ae8ed7d152a99f91223047e3875
https://doi.org/10.1080/07853890310011969

Zobrazit plný text záznamu

Safety and Immunogenicity of a Recombinant HIV Type 1 Glycoprotein 160 Boosted by a V3 Synthetic Peptide in HIV-Negative Volunteers

Autor: Brigitte Autran, Marie-Paule Kieny, Stanley A. Plotkin, Pascale Gonnet, Laurent Finkielstzjen, Thomas J. Matthews, Bernard Meignier, Philippe Blanche, Gustavo Gonzalez-Canali, Jean Claude Gluckman, Didier Sicard, Dominique Salmon-Ceron, Christian Valentin, Hervé Salomon, Jean-Louis Excler, Isabelle Diaz, Gilles Pialoux

Publikováno v: AIDS Research and Human Retroviruses. 11:1479-1486

The safety and the immunogenicity of a recombinant hybrid envelope glycoprotein MN/LAI (rgp160) followed by booster injections of a V3 (MN) linear peptide were evaluated in HIV-negative adults at low risk for HIV infection. Volunteers received either

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97820aaa8ec97ab9a03ad89cc2fb360a
https://doi.org/10.1089/aid.1995.11.1479

Zobrazit plný text záznamu

A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI)

Autor: Marie-Paule Kieny, Stanley A. Plotkin, Bernard Meignier, Thomas J. Matthews, Vincent Feuillie, Hervé Salomon, Gustavo Gonzalez-Canali, Jean-Louis Excler, Pierre Coulaud, L'agence Nationale De Recherche Sur Le Sida, Claude Meric, Pascale Gonnet, Yves Rivière, Enzo Paoletti, Jean Claude Gluckman, James Tartaglia, Gilles Pialoux, Isabelle Diaz

Publikováno v: AIDS Research and Human Retroviruses. 11:373-381

The safety and the immunogenicity of a recombinant canarypox live vector expressing the human immunodeficiency virus type 1 (HIV-1) gp160 gene from the MN isolate, ALVAC-HIV (vCP125), followed by booster injections of a soluble recombinant hybrid env

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::148395219ea708635919cddf35c7526e
https://doi.org/10.1089/aid.1995.11.373

Zobrazit plný text záznamu

A 3-Week Hepatitis B Vaccination Schedule Provides Rapid and Persistent Protective Immunity: A Multicenter, Randomized Trial Comparing Accelerated and Classic Vaccination Schedules

Autor: Joël Salaun, Jean-Emile Cerisier, Christiane Bourderioux, Bruno Marchou, Jean-Charles Auvergnat, Bernard Yvonnet, Hervé Salomon, Nicole Picot, Jean-Louis Excler

Publikováno v: Journal of Infectious Diseases. 172:258-260

Hepatitis B (HB) vaccinations given once weekly for 3 weeks can provide early seroprotection. This study compared immune responses induced by the accelerated (A; days 0, 10, 21) and classic (C; days 0, 28, 56) HB vaccination schedules. Two hundred se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29fe21ea09acff01891c72295cb5faf8
https://doi.org/10.1093/infdis/172.1.258

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání